STOCK TITAN
  1. Home
  2. Sec-filings
  3. VANI
  4. [Form 4] Vivani Medical, Inc. Insider Trading Activity

Gregg Williams (VANI) boosts Vivani Medical stake with 1,587,301-share private purchase

Filing Impact
(Very High)
Filing Sentiment
(Positive)
Form Type
4

Rhea-AI Filing Summary

Vivani Medical, Inc. director and 10% owner Gregg Williams reported a significant insider purchase of the company’s common stock. He acquired 1,587,301 shares in a private sale at $1.26 per share under a Share Purchase Agreement dated as of August 11, 2025, for gross transaction value of $1,999,999.26. Following this transaction, he beneficially owns 40,918,286 shares of Vivani common stock directly and through several trusts and LLCs over which he has voting and dispositive power.

Positive

  • None.

Negative

  • None.

Insights

Large insider purchase increases an already sizable Vivani Medical stake.

Director and 10% owner Gregg Williams bought 1,587,301 shares of Vivani Medical common stock at $1.26 per share in a private sale, totaling $1,999,999.26. This is reported as an open-market/private transaction under code P.

After the purchase, he controls 40,918,286 shares directly and via related entities, giving him substantial influence over voting decisions. The filing does not mention any 10b5-1 trading plan, so the acquisition appears discretionary based on the provided information.

This is a net-buy Form 4 with no derivative activity and no disclosed sales. Future company filings may further clarify how this concentrated ownership interacts with corporate governance and any potential strategic actions.

Insider Williams Gregg
Role null
Bought 1,587,301 shs ($2.00M)
Type Security Shares Price Value
Purchase Common Stock 1,587,301 $1.26 $2.00M
holding Common Stock -- -- --
Holdings After Transaction: Common Stock — 36,119,086 shares (Indirect, See footnote); Common Stock — 4,799,200 shares (Direct, null)
Footnotes (1)
  1. The reporting person purchased 1,587,301 shares of the Issuer's common stock in a private sale transaction as disclosed in the Share Purchase Agreement dated as of August 11, 2025 at a price of $1.26 per share, which was the last reported sale price of the Issuer's common stock on the Nasdaq on August 10, 2025 (the day immediately prior to August 11, 2025). The gross proceeds from this private sale transaction were $1,999,999.26. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased in the transaction set forth in this footnote. The reporting person owns 40,918,286 shares directly and/or indirectly as follows: (i) 4,799,200 shares of common stock owned by the reporting person, (ii) 33,993,334 shares of common stock owned by Gregg G. Williams 2006 Trust, (iii) 1,212,856 shares of common stock owned by Williams International Co. LLC, (iv) 181,587 shares of common stock owned by Sam Williams Family Investments LLC, and (v) 731,309 shares of common stock owned by Sam B. Williams 1995 Generation-Skipping Trust. Gregg Williams has voting and dispositive power over all of these shares.
Shares purchased 1,587,301 shares Common stock acquired in private sale transaction
Purchase price $1.26 per share Price for Vivani Medical common stock in private sale
Transaction value $1,999,999.26 Gross proceeds for the private sale transaction
Total beneficial ownership 40,918,286 shares Shares owned directly and indirectly after transaction
Direct holdings 4,799,200 shares Common stock owned directly by Gregg Williams
Trust holdings 33,993,334 shares Common stock held by Gregg G. Williams 2006 Trust
private sale transaction financial
"The reporting person purchased 1,587,301 shares of the Issuer's common stock in a private sale transaction"
Share Purchase Agreement financial
"in a private sale transaction as disclosed in the Share Purchase Agreement dated as of August 11, 2025"
A share purchase agreement is a written contract that outlines the terms and conditions for buying and selling shares of a company. It specifies details like the price, number of shares, and any special conditions, ensuring both buyer and seller agree on the transaction. For investors, it provides clarity and legal protection, making sure the purchase is clear and enforceable.
open-market purchase financial
"transaction_action": "open-market purchase""
An open-market purchase is when an investor or a company buys shares on a public stock exchange at the going market price, rather than through a private deal. It matters to investors because these purchases change how many shares are available, can push the stock price up or signal confidence from large buyers, and often affect per-share metrics like earnings—think of it like someone buying lots of apples off a grocery shelf, reducing supply and potentially raising the price.
voting and dispositive power financial
"Gregg Williams has voting and dispositive power over all of these shares."
beneficially owns financial
"The reporting person owns 40,918,286 shares directly and/or indirectly as follows"
Beneficially owns means a person or entity enjoys the economic benefits and control of a security even if the legal title or registration is held in another name. Think of it like having the keys and profits from a car that is registered to a friend: you use it, benefit from it, and make decisions about it even though the official paperwork lists someone else. For investors, this matters because it reveals who truly controls shares, affects voting power, potential conflicts of interest, and regulatory disclosure obligations.
See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Form 4 Insider Transactions: What Each Field Means →
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Williams Gregg
(Last)(First)(Middle)
C/O VIVANI MEDICAL, INC.
1350 S. LOOP ROAD
(Street)
ALAMEDA CALIFORNIA 94502
(City)(State)(Zip)
UNITED STATES
(Country)		2. Issuer Name and Ticker or Trading Symbol
Vivani Medical, Inc. [ VANI ] 		5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirectorX10% Owner
Officer (give title below)Other (specify below)
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
06/15/2026		6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock06/15/2026P(1)1,587,301A$1.2636,119,086ISee footnote(2)
Common Stock4,799,200D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Explanation of Responses:
1. The reporting person purchased 1,587,301 shares of the Issuer's common stock in a private sale transaction as disclosed in the Share Purchase Agreement dated as of August 11, 2025 at a price of $1.26 per share, which was the last reported sale price of the Issuer's common stock on the Nasdaq on August 10, 2025 (the day immediately prior to August 11, 2025). The gross proceeds from this private sale transaction were $1,999,999.26. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased in the transaction set forth in this footnote.
2. The reporting person owns 40,918,286 shares directly and/or indirectly as follows: (i) 4,799,200 shares of common stock owned by the reporting person, (ii) 33,993,334 shares of common stock owned by Gregg G. Williams 2006 Trust, (iii) 1,212,856 shares of common stock owned by Williams International Co. LLC, (iv) 181,587 shares of common stock owned by Sam Williams Family Investments LLC, and (v) 731,309 shares of common stock owned by Sam B. Williams 1995 Generation-Skipping Trust. Gregg Williams has voting and dispositive power over all of these shares.
/s/ Anthony Baldor, Attorney-in-fact06/16/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR

FAQ

What did Gregg Williams do in this Vivani Medical (VANI) Form 4 filing?

Gregg Williams reported buying 1,587,301 shares of Vivani Medical common stock in a private sale at $1.26 per share. This transaction increased his total beneficial holdings, which he controls directly and through several related entities.

How many Vivani Medical (VANI) shares did Gregg Williams purchase and at what price?

He purchased 1,587,301 shares of Vivani Medical common stock at $1.26 per share. The filing notes this was a private sale transaction, with terms set in a Share Purchase Agreement dated as of August 11, 2025.

What was the total dollar value of Gregg Williams’ Vivani Medical (VANI) share purchase?

The gross proceeds for the private sale transaction were $1,999,999.26. This represents the total value of the 1,587,301 Vivani Medical shares purchased at $1.26 per share, as detailed in the Form 4 footnotes.

How many Vivani Medical (VANI) shares does Gregg Williams own after this transaction?

After the reported purchase, Gregg Williams beneficially owns 40,918,286 Vivani Medical shares. This total includes 4,799,200 shares held directly and additional shares held through multiple trusts and LLCs he controls.

How are Gregg Williams’ Vivani Medical (VANI) shares held across different entities?

His 40,918,286 shares are held directly and via entities: 4,799,200 shares personally, 33,993,334 through the Gregg G. Williams 2006 Trust, 1,212,856 via Williams International Co. LLC, 181,587 via Sam Williams Family Investments LLC, and 731,309 through a generation-skipping trust.

Was Gregg Williams’ Vivani Medical (VANI) purchase an open-market or private transaction?

The Form 4 notes code P but the footnote clarifies it was a private sale transaction. The shares were purchased under a Share Purchase Agreement dated as of August 11, 2025, at a price equal to the last reported Nasdaq sale on August 10, 2025.